Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. IVQ

Invitrocue Limited (ASX: IVQ) - Share Price and Research

DELISTED - Current share price for IVQ : $0.060

Intelligent Investor free trial for buy hold sell stock recommendations

IVQ General Information +

ASX Code IVQ
Website N/A
Industry/Sector Biotechnology
Market Cap ($M) n/a
IVQ Share Price $0.060
Day High $0.000
Day Low $0.000
Last Close $0.060
IVQ Share Price Movement - ( No change )
Prices as at 16:40, 1 Mar 2021
+Security prices are delayed by at least 20 minutes and are indicative only.
Trial Banner Trial Banner Trial Banner
Upsell Banner

IVQ Related Research

Invitrocue Limited (IVQ) Upcoming Dividends & Yields

There are no dividends for Invitrocue Limited (IVQ). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Invitrocue Limited (IVQ) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Removal from Official List 26 Feb 2021 5:18PM $0.060 $0.060 $0.060 fallen by 0%
Final Director's Interest Notice - Chow Yee Koh 26 Feb 2021 5:06PM $0.060 $0.060 $0.060 fallen by 0%
Final Director's Interest Notice - Antony Eaton 26 Feb 2021 5:06PM $0.060 $0.060 $0.060 fallen by 0%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from Invitrocue Limited (IVQ) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

IVQ Directors

Name Position Start Date
Dr Boon Sing (Steven) Fang Chief Executive Officer, Managing Director, Executive Chairman 20 Jan 2016
Mr Chow Yee Koh Company Secretary 1 Jan 0001
Dr Andreas Lindner Non-Executive Director 7 Feb 2018

Invitrocue Limited (IVQ) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
23 Jul 2019 LINDNER, Andreas Buy Indirect Shares 434,946 $0.090 $39,145.140
27 Jun 2019 LINDNER, Andreas Buy Indirect Shares 930,000 $0.090 $83,700.000
18 Jun 2019 LINDNER, Andreas Buy Indirect Shares 210,000 $0.090 $18,900.000

See all changes in directors' interest & trades for Invitrocue Limited (IVQ) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IVQ Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (IVQ). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
115,739,987 (21.38%) Boon Sing Fang
95,295,785 (17.60%) Citicorp Nom PL
82,550,000 (15.25%) BNP Paribas Noms Pty Ltd
49,602,852 (9.16%) Hanry Yu

FAQs about Invitrocue Limited (IVQ)

Invitrocue Limited's (IVQ) current share price is $0.06. This constitutes a price movement of 0% when compared to the share price 7 days ago and is n/a below IVQ's 12-month high of n/a per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.06, Invitrocue Limited's (IVQ) current share price of $0.06 constitutes a movement of or 0%. Invitrocue Limited's (IVQ) share price movement is 0% when compared to 7 days ago and is n/a below IVQ's 52-week high of n/a.

Invitrocue Limited (IVQ) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for IVQ is a ratio that tells you the percentage of Invitrocue Limited's (IVQ) share price that it pays out in dividends each year.

Invitrocue Limited (IVQ) will release its next Annual Report on n/a. Invitrocue Limited's (IVQ) last annual report was released on 2 Oct 2019. Click here to view Invitrocue Limited's (IVQ) last annual report.

Invitrocue Limited (IVQ) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.